 randomized study effect hydroxychloroquine sulfate systemic lupus erythematosus Canadian Hydroxychloroquine Study Group BACKGROUND antimalarial drug hydroxychloroquine effective manifestations systemic lupus erythematosus effectiveness METHODS six-month double-blind placebo-controlled study effect hydroxychloroquine sulfate treatment patients stable systemic lupus erythematosus patients dose hydroxychloroquine placebo weeks patients group prednisone RESULTS relative risk clinical flare-up development specific clinical manifestations systemic lupus erythematosus increase severity times percent confidence interval patients placebo hydroxychloroquine patients flare-ups time flare-up relative risk severe exacerbation disease withdrawal study times percent confidence interval patients placebo patients severe exacerbations disease Changes dose prednisone different groups CONCLUSIONS Patients quiescent systemic lupus erythematosus hydroxychloroquine likely clinical flare-up drug